Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Genzyme General and BioMarin join forces to develop product for genetic disorder

June 8, 1998

Preclinical safety of maxacalcitol reviewed in depth

June 8, 1998

Teijin expands overseas to support development of TEI-6720

June 5, 1998

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

June 5, 1998

Fenofibrate capsules now available in U.S.

June 5, 1998

80-90% response rate obtained with Topiglan

June 4, 1998

More sildenafil clinical data presented at AUA; CPMP recommends European marketing approval

June 4, 1998

Harvard Scientific begins phase II trial with erectile dysfunction product

June 4, 1998

Transurethral alprostadil: conflicting results presented at AUA meeting

June 3, 1998

Vasomax phase III results presented at AUA meeting

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...